#Finotonlimab combined with SCT510 in advanced #HCC significantly improves overall survival and PFS, delivers a higher objective response rate, and maintains a manageable safety profile, highlighting its potential as a #FirstLineTherapy. #medsky
#STTT: doi.org/10.1038/s413...
0
0
0
0